Antiviral activity of 4'-thioIDU and thymidine analogs against orthopoxviruses

Viruses

Volumn 2, Issue 9, 2010, Pages 1968-1983

  Prichard, Mark N ^a   Kern, Earl R ^a  

^a UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

Author keywords

4' thioIDU; Antiviral; Deoxyuridine; IdoxuridIDU; Nucleoside; Orthopoxvirus; Pyrimidine

Indexed keywords

1 (2 DEOXY 4' THIO BETA DEXTRO RIBOFURANOSYL)THYMIDINE; 1 (4 THIO BETA DEXTRO ARABINOFURANOSYL) 5 FLUOROCYTIDINE; 4 THIO BETA DEXTRO ARABINOFURANOSYL CYTIDINE; 5 IODO 4 THIO 3',5' DI O ACETYL 2' DEOXYURIDINE; 5 IODO 4' THIO 2' DEOXYURIDINE; 5 TRIFLUOROMETHYL 2' DEOXY 4' THIOURIDINE; ANTIVIRUS AGENT; CIDOFOVIR; CIDOFOVIR 3 HEXADECYLOXYPROPYL ESTER; DEOXYURIDINE DERIVATIVE; DEOXYURIDINE TRIPHOSPHATE PYROPHOSPHATASE; DIDEOXY 6 AZATHYMIDINE 4' THIONUCLEOSIDE; DNA POLYMERASE; FIALURIDINE; IDOXURIDINE; METHANOCARBATHYMIDINE; RO 32 2313; TECOVIRIMAT; THYMIDINE DERIVATIVE; THYMIDINE KINASE 1; THYMIDINE KINASE INHIBITOR; THYMIDYLATE SYNTHASE; UNCLASSIFIED DRUG; VIRUS DNA;

ANTIVIRAL ACTIVITY; ANTIVIRAL RESISTANCE; COWPOX; COWPOX VIRUS; DRUG DEGRADATION; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENTIATION; DRUG STRUCTURE; DRUG TARGETING; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; ENZYME SPECIFICITY; GENE MUTATION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; POXVIRUS INFECTION; REVIEW; VACCINIA; VACCINIA VIRUS; VIRUS INHIBITION; VIRUS MORPHOLOGY; VIRUS REPLICATION;

ANIMALIA; ORTHOPOXVIRUS;

EID: 79952158137     PISSN: None     EISSN: 19994915     Source Type: Journal    
DOI: 10.3390/v2091968     Document Type: Review

References (68)

1. Kaufman, H.E.; Nesburn, A.B.; Maloney, E.D. Cure of vaccinia infection by 5-iodo-2'-deoxyuridine. Virology 1962, 18, 567-569.
2. Prusoff, W.H. Synthesis and biological activities of iododeoxyuridine, an analog of thymidine. Biochim. Biophys. Acta 1959, 32, 295-296.
3. Calabresi, P.; Mc, C.R.; Welch, A.D. Suppression of infections resulting from a deoxyribonucleic acid virus (vaccinia) by systemic adminstration of 5-iodo-2'-deoxyuridine. Nature 1963, 197, 767-769.
4. Loddo, B.; Muntoni, S.; Ferrari, W. Effect of 5-iodo-2'-deoxyuridine on vaccinia virus, in vitro. Nature 1963, 198, 510.
5. Prusoff, W.H.; Bakhle, Y.S.; McCrea, J.F. Incorporation of 5-Iodo-2'-Deoxyuridine into the deoxyribonucleic acid of vaccinia virus. Nature 1963, 199, 1310-1311.
6. Chen, M.S.; Ward, D.C.; Prusoff, W.H. Specific herpes simplex virus-induced incorporation of 5-iodo-5'-amino-2',5'-dideoxyuridine into deoxyribonucleic acid. J. Biol. Chem. 1976, 251, 4833-4838.
7. Chen, M.S.; Prusoff, W.H. Phosphorylation of 5-iodo-5'-amino-2',5',dideoxyuridine by herpes simplex virus type 1 encoded thymidine kinase. J. Biol. Chem. 1979, 254, 10449-10452.
8. Descamps, J.; De Clercq, E. Specific phosphorylation of E-5-(2-iodovinyl)-2'-deoxyuridine by herpes simplex virus-infected cells. J. Biol. Chem. 1981, 256, 5973-5976.
9. De Clercq, E. (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU). Med. Res. Rev. 2005, 25, 1-20.
10. Furman, P.A.; De Miranda, P.; St Clair, M.H.; Elion, G.B. Metabolism of acyclovir in virus-infected and uninfected cells. Antimicrob. Agents Chemother. 1981, 20, 518-524.
11. Kern, E.R. In vitro activity of potential anti-poxvirus agents. Antivir. Res. 2003, 57, 35-40.
12. De Clercq, E. Vaccinia virus inhibitors as a paradigm for the chemotherapy of poxvirus infections. Clin. Microbiol. Rev. 2001, 14, 382-397.
13. De Clercq, E. Antiviral and antitumor activities of 5-substituted 2'-deoxyuridines. Methods Find. Exp. Clin. Pharmacol. 1980, 2, 253-267.
14. Neyts, J.; Verbeken, E.; De Clercq, E. Effect of 5-iodo-2'-deoxyuridine on vaccinia virus (orthopoxvirus) infections in mice. Antimicrob. Agents Chemother. 2002, 46, 2842-2847.
15. De Clercq, E.; Luczak, M.; Shugar, D.; Torrence, P.F.; Waters, J.A.; Witkop, B. Effect of cytosine, arabinoside, iododeoxyuridine, ethyldeoxyuridine, thiocyanatodeoxyuridine, and ribavirin on tail lesion formation in mice infected with vaccinia virus. Proc. Soc. Exp. Biol. Med. 1976, 151, 487-490.
16. El Omari, K.; Solaroli, N.; Karlsson, A.; Balzarini, J.; Stammers, D.K. Structure of vaccinia virus thymidine kinase in complex with dTTP: Insights for drug design. BMC Struct. Biol. 2006, 6, 22.
17. Prichard, M.N.; Keith, K.A.; Johnson, M.P.; Harden, E.A.; McBrayer, A.; Luo, M.; Qiu, S.; Chattopadhyay, D.; Fan, X.; Torrence, P.F.; Kern, E.R. Selective phosphorylation of antiviral drugs by vaccinia virus thymidine kinase. Antimicrob. Agents Chemother. 2007, 51, 1795-1803.
18. Marquez, V.E.; Hughes, S.H.; Sei, S.; Agbaria, R. The history of N-methanocarbathymidine: The investigation of a conformational concept leads to the discovery of a potent and selective nucleoside antiviral agent. Antivir. Res. 2006, 71, 268-275.
19. Fan, X.; Zhang, X.; Zhou, L.; Keith, K.A.; Kern, E.R.; Torrence, P.F. Assembling a smallpox biodefense by interrogating 5-substituted pyrimidine nucleoside chemical space. Antivir. Res. 2006, 71, 201-205.
20. Fan, X.; Zhang, X.; Zhou, L.; Keith, K.A.; Kern, E.R.; Torrence, P.F. 5-(Dimethoxymethyl)-2'-deoxyuridine: A novel gem diether nucleoside with anti-orthopoxvirus activity. J. Med. Chem. 2006, 49, 3377-3382.
21. Fan, X.; Zhang, X.; Zhou, L.; Keith, K.A.; Kern, E.R.; Torrence, P.F. A pyrimidine-pyrazolone nucleoside chimera with potent in vitro anti-orthopoxvirus activity. Bioorg. Medicinal Chem. Letter. 2006, 16, 3224-3228.
22. Fan, X.; Zhang, X.; Zhou, L.; Keith, K.A.; Prichard, M.N.; Kern, E.R.; Torrence, P.F. Toward orthopoxvirus countermeasures: A novel heteromorphic nucleoside of unusual structure. J. Med. Chem. 2006, 49, 4052-4054.
23. Rahim, S.G.; Trivedi, N.; Bogunovic-Batchelor, M.V.; Hardy, G.W.; Mills, G.; Selway, J.W.; Snowden, W.; Littler, E.; Coe, P.L.; Basnak, I.; Whale, R.F.; Walker, R.T. Synthesis and anti-herpes virus activity of 2'-deoxy-4'-thiopyrimidine nucleosides. J. Med. Chem. 1996, 39, 789-795.
24. Secrist, J.A., 3rd; Tiwari, K.N.; Riordan, J.M.; Montgomery, J.A. Synthesis and biological activity of 2'-deoxy-4'-thio pyrimidine nucleosides. J. Med. Chem. 1991, 34, 2361-2366.
25. Kern, E.R.; Prichard, M.N.; Quenelle, D.C.; Keith, K.A.; Tiwari, K.N.; Maddry, J.A.; Secrist, J.A., 3rd. Activities of certain 5-substituted 4'-thiopyrimidine nucleosides against orthopoxvirus infections. Antimicrob. Agents Chemother. 2009, 53, 572-579.
26. Jasamai, M.; Balzarini, J.; Simons, C. 6-Azathymidine-4'-thionucleosides: Synthesis and antiviral evaluation. J. Enzyme. Inhib. Med. Chem. 2008, 23, 56-61.
27. Gammon, D.B.; Snoeck, R.; Fiten, P.; Krecmerova, M.; Holy, A.; De Clercq, E.; Opdenakker, G.; Evans, D.H.; Andrei, G. Mechanism of antiviral drug resistance of vaccinia virus: Identification of residues in the viral DNA polymerase conferring differential resistance to antipoxvirus drugs. J. Virol. 2008, 82, 12520-12534.
28. Andrei, G.; Gammon, D.B.; Fiten, P.; De Clercq, E.; Opdenakker, G.; Snoeck, R.; Evans, D.H. Cidofovir resistance in vaccinia virus is linked to diminished virulence in mice. J. Virol. 2006, 80, 9391-9401.
29. Smee, D.F.; Wandersee, M.K.; Bailey, K.W.; Hostetler, K.Y.; Holy, A.; Sidwell, R.W. Characterization and treatment of cidofovir-resistant vaccinia (WR strain) virus infections in cell culture and in mice. Antivir. Chem. Chemother. 2005, 16, 203-211.
30. Becker, M.N.; Obraztsova, M.; Kern, E.R.; Quenelle, D.C.; Keith, K.A.; Prichard, M.N.; Luo, M.; Moyer, R.W. Isolation and characterization of cidofovir resistant vaccinia viruses. Virol. J. 2008, 5, 58.
31. Prichard, M.N.; Kern, E.R. Orthopoxvirus targets for the development of antiviral therapies. Curr. Drug Targets Infect. Disord. 2005, 5, 17-28.
32. Prichard, M.N.; Kern, E.R. Antiviral targets in orthopoxviruses. In Antiviral Research: Strategies in Antiviral Drug Discovery; LaFemina, R.L., Ed.; ASM Press: Washington, DC, USA, 2009; pp. 167-186.
33. Kit, S.; Piekarski, L.J.; Dubbs, D.R. Induction of thymidine kinase by vaccinia-infected mouse fibroblasts. J. Mol. Biol. 1963, 6, 22-33.
34. Prichard, M.N.; Williams, A.D.; Keith, K.A.; Harden, E.A.; Kern, E.R. Distinct thymidine kinases encoded by cowpox virus and herpes simplex virus contribute significantly to the differential antiviral activity of nucleoside analogs. Antivir. Res. 2006, 71, 1-6.
35. Lefkowitz, E.J.; Wang, C.; Upton, C. Poxviruses: Past, present and future. Virus Res. 2006, 117, 105-118.
36. Black, M.E.; Hruby, D.E. Site-directed mutagenesis of a conserved domain in vaccinia virus thymidine kinase. Evidence for a potential role in magnesium binding. J. Biol. Chem. 1992, 267, 6801-6806.
37. Hruby, D.E.; Maki, R.A.; Miller, D.B.; Ball, L.A. Fine structure analysis and nucleotide sequence of the vaccinia virus thymidine kinase gene. Proc. Natl. Acad. Sci. U.S.A. 1983, 80, 3411-3415.
38. Black, M.E.; Hruby, D.E. A single amino acid substitution abolishes feedback inhibition of vaccinia virus thymidine kinase. J. Biol. Chem. 1992, 267, 9743-9748.
39. Solaroli, N.; Johansson, M.; Balzarini, J.; Karlsson, A. Substrate specificity of three viral thymidine kinases (TK): Vaccinia virus TK, feline herpesvirus TK, and canine herpesvirus TK. Nucleosides Nucleotides Nucleic Acids 2006, 25, 1189-1192.
40. Prichard, M.N.; Keith, K.A.; Quenelle, D.C.; Kern, E.R. Activity and mechanism of action of N-methanocarbathymidine against herpesvirus and orthopoxvirus infections. Antimicrob. Agents Chemother. 2006, 50, 1336-1341.
41. Smee, D.F.; Humphreys, D.E.; Hurst, B.L.; Barnard, D.L. Antiviral activities and phosphorylation of 5-halo-2'-deoxyuridines and N-methanocarbathymidine in cells infected with vaccinia virus. Antivir. Chem. Chemother. 2008, 19, 15-24.
42. Harden, E.A.; Keith, K.A.; Daily, S.; Tiwari, K.; Maddry, J.; Secrist, J.; Kern, E.R.; Prichard, M.N. Mutation of the thymidine kinases encoded by herpes simplex virus or vaccinia virus can confer resistance to 5-iodo-4'-thio-2'-deoxyuridine. Antivir. Res. 2009, 82, A48.
43. Birringer, M.S.; Claus, M.T.; Folkers, G.; Kloer, D.P.; Schulz, G.E.; Scapozza, L. Structure of a type II thymidine kinase with bound dTTP. FEBS Lett. 2005, 579, 1376-1382.
44. Hughes, S.J.; Johnston, L.H.; De Carlos, A.; Smith, G.L. Vaccinia virus encodes an active thymidylate kinase that complements a cdc8 mutant of Saccharomyces cerevisiae. J. Biol. Chem. 1991, 266, 20103-20109.
45. Caillat, C.; Topalis, D.; Agrofoglio, L.A.; Pochet, S.; Balzarini, J.; Deville-Bonne, D.; Meyer, P. Crystal structure of poxvirus thymidylate kinase: An unexpected dimerization has implications for antiviral therapy. Proc. Natl. Acad. Sci. U.S.A. 2008, 105, 16900-16905.
46. Topalis, D.; Collinet, B.; Gasse, C.; Dugue, L.; Balzarini, J.; Pochet, S.; Deville-Bonne, D. Substrate specificity of vaccinia virus thymidylate kinase. FEBS J. 2005, 272, 6254-6265.
47. Auvynet, C.; Topalis, D.; Caillat, C.; Munier-Lehmann, H.; Seclaman, E.; Balzarini, J.; Agrofoglio, L.A.; Kaminski, P.A.; Meyer, P.; Deville-Bonne, D.; El Amri, C. Phosphorylation of dGMP analogs by vaccinia virus TMP kinase and human GMP kinase. Biochem. Biophys. Res. Commun. 2009, 388, 6-11.
48. Goebel, S.J.; Johnson, G.P.; Perkus, M.E.; Davis, S.W.; Winslow, J.P.; Paoletti, E. The complete DNA sequence of vaccinia virus. Virology 1990, 179, 247-266, 517-263.
49. Broyles, S.S. Vaccinia virus encodes a functional dUTPase. Virology 1993, 195, 863-865.
50. Roseman, N.A.; Evans, R.K.; Mayer, E.L.; Rossi, M.A.; Slabaugh, M.B. Purification and characterization of the vaccinia virus deoxyuridine triphosphatase expressed in Escherichia coli. J. Biol. Chem. 1996, 271, 23506-23511.
51. Prichard, M.N.; Kern, E.R.; Quenelle, D.C.; Keith, K.A.; Moyer, R.W.; Turner, P.C. Vaccinia virus lacking the deoxyuridine triphosphatase gene (F2L) replicates well in vitro and in vivo, but is hypersensitive to the antiviral drug (N)-methanocarbathymidine. Virol. J. 2008, 5, 39.
52. Keith, K.A.; Harden, E.A.; Gill, R.; Marquez, V.E.; Kern, E.R.; Prichard, M.N. Efficacy of N-methanocarbathymidine against herpes simplex virus is cell cycle dependent. Antivir. Res. 2010, 86, A58.
53. Smee, D.F.; Wandersee, M.K.; Bailey, K.W.; Wong, M.H.; Chu, C.K.; Gadthula, S.; Sidwell, R.W. Cell line dependency for antiviral activity and in vivo efficacy of N-methanocarbathymidine against orthopoxvirus infections in mice. Antivir. Res. 2007, 73, 69-77.
54. Sauerbrei, A.; Meier, C.; Meerbach, A.; Schiel, M.; Helbig, B.; Wutzler, P. In vitro activity of cycloSal-nucleoside monophosphates and polyhydroxycarboxylates against orthopoxviruses. Antivir. Res. 2005, 67, 147-154.
55. Schelling, P.; Claus, M.T.; Johner, R.; Marquez, V.E.; Schulz, G.E.; Scapozza, L. Biochemical and structural characterization of (South)-methanocarbathymidine that specifically inhibits growth of herpes simplex virus type 1 thymidine kinase-transduced osteosarcoma cells. J. Biol. Chem. 2004, 279, 32832-32838.
56. Martin, J.A.; Thomas, G.J.; Merrett, J.H.; Lambert, R.W.; Bushnell, D.J.; Dunsdon, S.J.; Freeman, A.C.; Hopkins, R.A.; Johns, I.R.; Keech, E.; Simmonite, H.; Kai-In, P.W.; Holland, M. The design, synthesis and properties of highly potent and selective inhibitors of herpes simplex virus types 1 and 2 thymidine kinase. Antivir. Chem. Chemother. 1998, 9, 1-8.
57. Zalah, L.; Huleihel, M.; Manor, E.; Konson, A.; Ford, H., Jr.; Marquez, V.E.; Johns, D.G.; Agbaria, R. Metabolic pathways of N-methanocarbathymidine, a novel antiviral agent, in native and herpes simplex virus type 1 infected Vero cells. Antivir. Res. 2002, 55, 63-75.
58. Chen, M.S.; Walker, J.; Prusoff, W.H. Kinetic studies of herpes simplex virus type 1-encoded thymidine and thymidylate kinase, a multifunctional enzyme. J. Biol. Chem. 1979, 254, 10747-10753.
59. Prota, A.; Vogt, J.; Pilger, B.; Perozzo, R.; Wurth, C.; Marquez, V.E.; Russ, P.; Schulz, G.E.; Folkers, G.; Scapozza, L. Kinetics and crystal structure of the wild-type and the engineered Y101F mutant of Herpes simplex virus type 1 thymidine kinase interacting with (North)-methanocarba-thymidine. Biochemistry 2000, 39, 9597-9603.
60. Marquez, V.E.; Siddiqui, M.A.; Ezzitouni, A.; Russ, P.; Wang, J.; Wagner, R.W.; Matteucci, M.D. Nucleosides with a twist. Can fixed forms of sugar ring pucker influence biological activity in nucleosides and oligonucleotides? J. Med. Chem 1996, 39, 3739-3747.
61. Marquez, V.E.; Ben-Kasus, T.; Barchi, J.J., Jr.; Green, K.M.; Nicklaus, M.C.; Agbaria, R. Experimental and structural evidence that herpes 1 kinase and cellular DNA polymerase(s) discriminate on the basis of sugar pucker. J. Am. Chem. Soc. 2004, 126, 543-549.
62. Smee, D.F.; Hurst, B.L.; Wong, M.H.; Glazer, R.I.; Rahman, A.; Sidwell, R.W. Efficacy of N-methanocarbathymidine in treating mice infected intranasally with the IHD and WR strains of vaccinia virus. Antivir. Res. 2007, 76, 124-129.
63. De Clercq, E.; Descamps, J.; Huang, G.F.; Torrence, P.F. 5-Nitro-2'-deoxyuridine and 5-nitro-2'-deoxyuridine 5'-monophosphate: Antiviral activity and inhibition of thymidylate synthetase in vivo. Mol. Pharmacol. 1978, 14, 422-430.
64. Quenelle, D.C. University of Alabama at Birmingham, Birmingham, AL, USA. Personal Communication, 2010.
65. Prichard, M.N.; Quenelle, D.C.; Hartline, C.B.; Harden, E.A.; Jefferson, G.; Frederick, S.L.; Daily, S.L.; Whitley, R.J.; Tiwari, K.N.; Maddry, J.A.; Secrist, J.A., 3rd; Kern, E.R. Inhibition of herpesvirus replication by 5-substituted 4'-thiopyrimidine nucleosides. Antimicrob. Agents Chemother. 2009, 53, 5251-5258.
66. Taupin, P. BrdU immunohistochemistry for studying adult neurogenesis: Paradigms, pitfalls, limitations, and validation. Brain Res. Rev. 2007, 53, 198-214.
67. Smee, D.F.; Sidwell, R.W. Anti-cowpox virus activities of certain adenosine analogs, arabinofuranosyl nucleosides, and 2'-fluoro-arabinofuranosyl nucleosides. Nucleosides Nucleotides Nucleic Acids 2004, 23, 375-383.
68. Keith, K.A.; Sanders, S.; Tiwari, K.; Maddry, J.; Secrist, J.; Jordan, R.; Hruby, D.; Lanier, R.; Painter, G.; Kern, E.R.; Prichard, M.N. Combinations of 5-iodo-4'-thio-2'-deoxyuridine and ST-246 or CMX001 synergistically inhibit orthopoxvirus replication in vitro. Antivir. Res. 2009, 82, A33-A34.